for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Acasti Pharma Inc

ACST.OQ

前日終値

2.04USD

変化

-0.14(-6.42%)

出来高

226,919

本日のレンジ

1.99

 - 

2.18

52週レンジ

0.61

 - 

2.95

∙ 約15分前の相場を表示しています。

価格

前日終値
2.18
始値
2.18
出来高
226,919
3か月平均出来高
3.56
高値
2.18
安値
1.99
52週高値
2.95
52週安値
0.61
発行済株式数
85.19
時価総額
241.08
予想PER
-8.58
配当利回り
--

次のエベント

Q2 2020 Acasti Pharma Inc Earnings Release

適時開示

その他

Acasti Pharma Inc - QTRLY Loss Per Share $0.15

Neptune Wellness Solutions Inc Says Now Holds About 3 Million Shares Of Acasti Pharma, Representing 3.8% Of The Outstanding Shares Of The Acasti Pharma.

Acasti Pharma Provides Update on Trilogy 2 Trial

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Acasti Pharma Incとは

Acasti Pharma Inc is a Canada-based biopharmaceutical company. The Company is focused on the research, development and commercialization of prescription drugs using omega 3 fatty acids (OM3s) derived from krill oil. OM3s has clinical evidence of safety and efficacy in lowering triglycerides in patients with hypertriglyceridemia (HTG). The Company's drug candidate is CaPre, an OM3 phospholipid, which is being developed for the treatment of severe hypertriglyceridemia, a condition characterized by abnormally high levels of triglycerides in the bloodstream (over 500 mg/dL) (severe hypertriglyceridemia or severe HTG).

業種

Biotechnology & Drugs

連絡先

545 Prom du Centropolis Suite 100

+1.450.6864555

https://www.acastipharma.com/

エグゼクティブリーダーシップ

Roderick Noel Carter

Executive Chairman of the Board

Janelle D'Alvise

President, Chief Executive Officer, Director

Linda Parinella O'Keefe

Chief Financial Officer

Pierre Lemieux

Chief Operating Officer

Jean-Francois Boily

Vice President - Finance

統計

2.00 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, CAD)

2019

0.0K

2020(E)

0.0K
EPS (CAD)

2017

-0.970

2019

-0.950

2020(E)

-0.265
株価売上高倍率(過去12カ月)
--
株価売上高倍率(過去12カ月)
--
株価純資産倍率(四半期)
62.72
株価キャッシュフロー倍率
--
総負債/総資本(四半期)
52.34
長期負債/資本(四半期)
0.00
投資利益率(過去12カ月)
-296.42
自己資本利益率(過去12カ月)
-170.80

最新ニュース

最新ニュース

金融情報はリフィニティブから。すべての情報は少なくとも15分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up